Genco Lab was accused of billing Medicaid and Medicare programs for unnecessary screening and confirmatory tests for the use of prohibited drugs.

Genco Lab was accused of billing Medicaid and Medicare programs for unnecessary screening and confirmatory tests for the use of prohibited drugs.

The new ruling reverses a jury verdict from four years ago that handed ArcherDx, which no longer exists, $4.7 million in damages.

The US Food and Drug Administration granted clearances for PCR-based infectious disease tests from multiple entities as well as other in vitro diagnostic tests.

TBI is a potential new application area for the 8-year-old company, while it continues to commercialize its stroke triage test.